---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-367001"
form_type: "8-K"
ticker: "OKUR"
cik: "0001637715"
company_name: "OnKure Therapeutics, Inc."
filed_at: "2021-12-27T23:59:59+00:00"
generated_at: "2026-06-27T22:20:14.504086+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Reneo Pharma CBO Wendy Johnson to depart Dec 31, enters consulting agreement

## Summary
- Wendy Johnson will cease as CBO on Dec 31, 2021; will serve as consultant for 18 months.
- Severance of $100k contingent on release of claims; continues base salary of $365k/yr until separation.
- Equity awards continue to vest during consulting period; full acceleration if Company terminates without cause before June 30, 2023.
- Cash consulting fee of $10k/month plus hourly rate for over 32 hours/month.

## SEC filing metadata
- accession: 0001193125-21-367001
- form_type: 8-K
- ticker: OKUR
- cik: 0001637715
- company_name: OnKure Therapeutics, Inc.
- filed_at: 2021-12-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1637715/000119312521367001/0001193125-21-367001-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1637715/000119312521367001/d237276d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-367001
- JSON: https://secwatch.observer/filing/0001193125-21-367001.json
- Plain text: https://secwatch.observer/filing/0001193125-21-367001.txt

## Key facts
- Executive change
  Wendy Johnson resigned as Chief Business Officer at OnKure Therapeutics, Inc..
  - Action: resigned
  - Role: Chief Business Officer
  source text: On December 23, 2021, Reneo Pharmaceuticals, Inc. (the “Company”) entered into a Transition, Separation and Consulting Agreement (the “Agreement”) with Wendy Johnson, in connection with her previously announced resignation from the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1637715/000119312521367001/0001193125-21-367001-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.